467 related articles for article (PubMed ID: 15744817)
21. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
22. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
[TBL] [Abstract][Full Text] [Related]
23. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
24. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
25. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
26. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
Takeuchi S; Hiromura K; Tomioka M; Takahashi S; Sakairi T; Maeshima A; Kaneko Y; Kuroiwa T; Nojima Y
Nephron Exp Nephrol; 2010; 116(1):e3-10. PubMed ID: 20502051
[TBL] [Abstract][Full Text] [Related]
27. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
[TBL] [Abstract][Full Text] [Related]
28. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
[TBL] [Abstract][Full Text] [Related]
29. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
30. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
[TBL] [Abstract][Full Text] [Related]
31. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
32. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.
Suzuki A; Ito T; Imai E; Yamato M; Iwatani H; Kawachi H; Hori M
J Am Soc Nephrol; 2003 Apr; 14(4):981-91. PubMed ID: 12660332
[TBL] [Abstract][Full Text] [Related]
33. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
Hattori T; Ito M; Suzuki Y
Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
[TBL] [Abstract][Full Text] [Related]
34. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
[TBL] [Abstract][Full Text] [Related]
35. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
36. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Shinosaki T; Takagawa I; Sunagawa N; Yonetani Y; Kurihara H
Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
38. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A
Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
